Partisan Lines Form over Dem Drug Price Curbs, Economic Plan

July 19, 2022by Alan Fram, Associated Press
Partisan Lines Form over Dem Drug Price Curbs, Economic Plan
Senate Majority Whip Dick Durbin, D-Ill., joined at right by Senate Majority Leader Chuck Schumer, D-N.Y., takes a question during a news conference following a closed-door policy lunch, at the Capitol in Washington, May 24, 2022. (AP Photo/J. Scott Applewhite, File)

WASHINGTON (AP) — Senate Minority Leader Mitch McConnell is warning that Democrats’ plans to curb drug prices would insert “socialist price controls” between Americans and the treatments they need as partisan battle lines form over a shrunken economic package that President Joe Biden wants Congress to complete within weeks.

“Bring it on,” No. 2 Senate Democratic leader Dick Durbin of Illinois told reporters in response Monday, underscoring his party’s hopes that the fight would buttress them in November’s congressional elections. “This prescription drug issue is an inflation issue. It’s a public health issue. It’s a cost to the government issue. And it’s something the American people get.”

Biden conceded last week he would settle for a far narrower economic plan than he’d sought at the beginning of his presidency. Capitulating to Sen. Joe Manchin, D-W.Va., Biden said he wanted Democrats to quickly write and pass a measure limiting pharmaceutical prices, extending expiring subsidies for people buying health insurance and modestly reducing federal deficits.

Manchin, one of his party’s most conservative members, a fossil fuel champion and an indispensable vote in the 50-50 Senate, announced last week that those were the only elements he was willing to include in the legislation. He cited concerns about inflation that’s risen rapidly this year. Manchin’s remarks meant Democrats’ hopes of including efforts to reverse climate change were at best a long shot this year.


“I haven‘t walked away from anything,” the West Virginian told reporters Monday about months long talks over the party’s economic push, now seemingly on life support, with Senate Majority Leader Chuck Schumer, D-N.Y. He called inflation his “greatest concern” and added, “I don’t know what tomorrow brings.”

While Democrats largely seemed ready to accept the pared-down bill and claim an election-season achievement, Manchin’s performance is clearly wearing on many. His objections spiked most of Biden’s multitrillion-dollar aspirations to strengthen child care and other social programs and raise taxes on the rich, contributing to criticisms that Democrats have fallen short while controlling the White House and — narrowly — Congress.

“I think Joe should have made his position clear a hell of a long time ago,” Durbin said. “We’ve spent a lot of time, wasted a lot of time on negotiation.”

House Speaker Nancy Pelosi, D-Calif., told fellow Democrats in a letter that the Senate’s proposed health provisions “are essential, as we must act to reduce the cost of prescription drugs.” Said Sen. Elizabeth Warren, D-Mass.: “We have waited a year and a half for 50 votes. It’s time to move where we can move.”

The prescription drug measure negotiated by Schumer and Manchin would let Medicare negotiate prices for the pharmaceuticals it buys, require manufacturers to pay rebates for some price increases, clamp a $2,000 annual ceiling on Medicare recipients’ out-of-pocket drug costs and provide free vaccines for older people.

The nonpartisan Congressional Budget Office said the proposal would save the government $288 billion over the coming decade, chiefly because the government would pay less for pharmaceuticals. The extended health care subsidies would use some of that money, with the rest for deficit reduction.

McConnell said the proposal would punish an industry that delivered COVID-19 vaccines just two years ago, a remarkably rapid and effective achievement, and hurt patients.


“Washington Democrats are working right now, right now to find ways to put more bureaucracy between American patients and the treatments they rely on,” he said. “They want to put socialist price controls between American innovators and new cures for debilitating diseases.”

White House officials touted the benefits of shoring up subsidies for millions to purchase coverage under the Affordable Care Act and reducing the cost of prescription drugs. Both are longtime Democratic goals.

“We’re on the cusp of a very big win here” on health care, said White House press secretary Karine Jean-Pierre. She reiterated a pledge from Biden last week to take executive action if Congress fails to act on climate, but offered no specifics of what Biden might do.

Notably, Schumer did not mention the economic legislation as the Senate began its session Monday. Democratic senators seemed certain to discuss their plans during their weekly Tuesday lunch. Biden and party leaders hope to approve a package over likely unanimous Republican opposition before Congress begins its August recess.

Manchin has said he would consider climate change legislation in September once he’s seen updated inflation figures. Approving a measure in the heat of election campaigns would be extremely difficult. Republicans seem likely to win House control and have a realistic chance of capturing the Senate as well.

The Pharmaceutical Research and Manufacturers of America, known as PhRMA, the industry’s most influential lobbying group, said Democrats’ latest bill had gone “from bad to worse for patients.” Spokesperson Debra DeShong said the measure would “threaten patient access and future innovations.”

PhRMA said its member companies spent a record $102.3 billion on research and development last year.

Overall, the industry spent $83 billion on research and development in 2019, 10 times the inflation-adjusted value of what it spent annually in the 1980s, the nonpartisan Congressional Budget Office said in a report last year.

Drugmakers on average spent a quarter of their net revenues on R&D in 2019, a far larger proportion than the semiconductor, technology hardware and software industries, the budget office said.


___

Associated Press writers Seung Min Kim and Matthew Perrone contributed to this report.

A+
a-

In The News

Health

Voting

Political News

August 16, 2022
by Dan McCue
Biden Signs Inflation Reduction Act in Modest White House Ceremony

WASHINGTON — Looking fresh and relaxed from a week vacationing in Kiawah Island, South Carolina, President Joe Biden returned to... Read More

WASHINGTON — Looking fresh and relaxed from a week vacationing in Kiawah Island, South Carolina, President Joe Biden returned to the White House this afternoon to sign the so-called Inflation Reduction Act and deliver on what he’s called the “final piece” of his domestic agenda. Standing... Read More

August 16, 2022
by Tom Ramstack
Environmental Justice Index Announced to Help Guide Federal Policy

WASHINGTON — The Department of Health and Human Services is launching a new online tool to help communities gauge the... Read More

WASHINGTON — The Department of Health and Human Services is launching a new online tool to help communities gauge the extent pollution is contributing to health risks for their residents. It is intended primarily to benefit residents of disadvantaged communities. The tool, called the Environmental Justice... Read More

August 16, 2022
by Dan McCue
AG to Appoint Election Monitor to Oversee Upcoming New Hampshire Primary

CONCORD, N.H. — State Attorney General John Formella announced Tuesday that he will appoint an election monitor to oversee the... Read More

CONCORD, N.H. — State Attorney General John Formella announced Tuesday that he will appoint an election monitor to oversee the state’s Sept. 13 primary elections after an investigation revealed a pattern of apparent mistakes made in past contests. The events that led to the decision mostly... Read More

August 16, 2022
by Dan McCue
First Lady Tests Positive for COVID-19

KIAWAH ISLAND, S.C — First Lady Dr. Jill Biden is isolating after a positive test for COVID-19 Tuesday morning, a... Read More

KIAWAH ISLAND, S.C — First Lady Dr. Jill Biden is isolating after a positive test for COVID-19 Tuesday morning, a spokesperson for her office said Tuesday. “After testing negative for COVID-19 on Monday during her regular testing cadence, the first lady began to develop cold-like symptoms... Read More

August 15, 2022
by Dan McCue
Schatz, Case and Tokuda Prevail in Hawaiian Primaries

HONOLULU, Hawaii — Blue Dog Democrat Rep. Ed Case, incumbent Democratic Sen. Brian Schatz, and Hawaii’s current Democratic Lt. Gov.... Read More

HONOLULU, Hawaii — Blue Dog Democrat Rep. Ed Case, incumbent Democratic Sen. Brian Schatz, and Hawaii’s current Democratic Lt. Gov. Josh Green won their respective primary contests on Saturday. The state’s top vote getter on Saturday was Schatz, who was serving as lieutenant governor when he... Read More

August 13, 2022
by Dan McCue
Alaskans to Get First Taste of Ranked Choice Voting

WASHINGTON — Alaskans heading to the polls for the state’s primary election on Tuesday will get their first, limited exposure... Read More

WASHINGTON — Alaskans heading to the polls for the state’s primary election on Tuesday will get their first, limited exposure to ranked choice voting in a special House election taking place the same day, and featuring Republicans Sarah Palin and Nick Begich, and Democrat Mary Peltola.... Read More

News From The Well
scroll top